Title 21 Code of Federal Regulations

PART 1308 — SCHEDULES OF CONTROLLED SUBSTANCES

EXCLUDED NONNARCOTIC SUBSTANCES

SCHEDULES

§1308.13 Schedule III.

(a) Schedule III shall consist of the drugs and other substances, by whatever official name, common or usual name, chemical name, or brand name designated, listed in this section. Each drug or substance has been assigned the DEA Controlled Substances Code Number set forth opposite it.

(b) Stimulants. Unless specifically excepted or unless listed in another schedule, any material, compound, mixture, or preparation which contains any quantity of the following substances having a stimulant effect on the central nervous system, including its salts, isomers (whether optical, positional, or geometric), and salts of such isomers whenever the existence of such salts, isomers, and salts of isomers is possible within the specific chemical designation:

(1) Those compounds, mixtures, or preparations in dosage unit form containing any stimulant substances listed in schedule II which compounds, mixtures, or preparations were listed on August 25, 1971, as excepted compounds under §1308.32, and any other drug of the quantitative composition shown in that list for those drugs or which is the same except that it contains a lesser quantity of controlled substances

1405

(2) Benzphetamine

1228

(3) Chlorphentermine

1645

(4) Clortermine

1647

(5) Phendimetrazine

1615

(c) Depressants. Unless specifically excepted or unless listed in another schedule, any material, compound, mixture, or preparation which contains any quantity of the following substances having a depressant effect on the central nervous system:

(1) Any compound, mixture or preparation containing:

(i) Amobarbital

2126

(ii) Secobarbital

2316

(iii) Pentobarbital

2271

or any salt thereof and one or more other active medicinal ingredients which are not listed in any schedule.

(2) Any suppository dosage form containing:

(i) Amobarbital

2126

(ii) Secobarbital

2316

(iii) Pentobarbital

2271

or any salt of any of these drugs and approved by the Food and Drug Administration for marketing only as a suppository.

(3) Any substance which contains any quantity of a derivative of barbituric acid or any salt thereof

2100

(4) Chlorhexadol

2510

(5) Embutramide

2020

(6) Any drug product containing gamma hydroxybutyric acid, including its salts, isomers, and salts of isomers, for which an application is approved under section 505 of the Federal Food, Drug, and Cosmetic Act

2012

(7) Ketamine, its salts, isomers, and salts of isomers

7285

[Some other names for ketamine:
(±)-2-(2-chlorophenyl)-2-(methylamino)-cyclohexanone]

(8) Lysergic acid

7300

(9) Lysergic acid amide

7310

(10) Methyprylon

2575

(11) Perampanel, and its salts, isomers, and salts of isomers

2261

(12) Sulfondiethylmethane

2600

(13) Sulfonethylmethane

2605

(14) Sulfonmethane

2610

(15) Tiletamine and zolazepam or any salt thereof

7295

Some trade or other names for a tiletamine-zolazepam combination product:
Telazol

Some trade or other names for tiletamine:
2-(ethylamino)-2-(2-thienyl)-cyclohexanone

Some trade or other names for zolazepam:
4-(2-fluorophenyl)-6,8-dihydro-1,3,8-trimethylpyrazolo-[3,4-e] [1,4]-diazepin-7(1H)-one, flupyrazapon

(1) Any material, compound, mixture, or preparation containing any of the following narcotic drugs, or their salts calculated as the free anhydrous base or alkaloid, in limited quantities as set forth below:

(i) Not more than 1.8 grams of codeine per 100 milliliters or not more than 90 milligrams per dosage unit, with an equal or greater
quantity of an isoquinoline alkaloid of opium

9803

(ii) Not more than 1.8 grams of codeine per 100 milliliters or not more than 90 milligrams per dosage unit, with one or more active,
nonnarcotic ingredients in recognized therapeutic amounts

9804

(iii) Not more than 1.8 grams of dihydrocodeine per 100 milliliters or not more than 90 milligrams per dosage unit, with one or more
active nonnarcotic ingredients in recognized therapeutic amounts

9807

(iv) Not more than 300 milligrams of ethylmorphine per 100 milliliters or not more than 15 milligrams per dosage unit, with one or
more active, nonnarcotic ingredients in recognized therapeutic amounts

9808

(v) Not more than 500 milligrams of opium per 100 milliliters or per 100 grams or not more than 25 milligrams per dosage unit, with
one or more active, nonnarcotic ingredients in recognized therapeutic amounts

9809

(vi) Not more than 50 milligrams of morphine per 100 milliliters or per 100 grams, with one or more active, nonnarcotic ingredients
in
recognized therapeutic amounts

9810

(2) Any material, compound, mixture, or preparation containing any of the following narcotic drugs or their salts, as set forth below:

(i) Buprenorphine

9064

(ii) [Reserved]

(f) Anabolic Steroids. Unless specifically excepted or unless listed in another schedule, any material, compound, mixture or preparation containing any quantity of the following substances, including its salts, esters and ethers: